{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:39:17Z","timestamp":1783708757323,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dental Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jds.2023.04.026","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:28:33Z","timestamp":1683707313000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-536X","authenticated-orcid":false,"given":"Mitsunobu","family":"Otsuru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Soutome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hotokezaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Rokutanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jds.2023.04.026_bib1","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jds.2023.04.026_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jds.2023.04.026_bib3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.jds.2023.04.026_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.jds.2023.04.026_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent J"},{"key":"10.1016\/j.jds.2023.04.026_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3803\/EnM.2021.1170","article-title":"Review and update of the risk factors and prevention of antiresorptive-related osteonecrosis of the jaw","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.jds.2023.04.026_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jds.2023.04.026_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","article-title":"Prevalence, incidence rate, and risk factors of medication-related osteonecrosis and cancer: a nationwide population-based study in Japan","volume":"80","author":"Ishimaru","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2023.04.026_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2019.04.010","article-title":"Pharmacogenomics of osteonecrosis of the jaw","volume":"124","author":"Yang","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.jds.2023.04.026_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.4185","article-title":"SIRT1 Gene SNP rs932658 is associated with medication-related osteonecrosis of the jaw","volume":"36","author":"Yang","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jds.2023.04.026_bib11","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.M115.652305","article-title":"Osteonecrosis of the jaw developed in mice: disease variants regulated by \u03b3\u03b4T cells in oral mucosal barrier immunity","volume":"290","author":"Park","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jds.2023.04.026_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.jds.2023.04.026_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"Reply: American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jds.2023.04.026_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?","volume":"43","author":"Otto","year":"2015","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.jds.2023.04.026_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201343","article-title":"Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor?","volume":"13","author":"Soutome","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jds.2023.04.026_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96480-8","article-title":"Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients","volume":"11","author":"Soutome","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jds.2023.04.026_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11282-013-0135-3","article-title":"Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis","volume":"29","author":"Suei","year":"2013","journal-title":"Oral Radiol"},{"key":"10.1016\/j.jds.2023.04.026_bib18","doi-asserted-by":"crossref","DOI":"10.1259\/dmfr.20160065","article-title":"Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?","volume":"45","author":"Klingelh\u00f6ffer","year":"2016","journal-title":"Dentomaxillofacial Radiol"},{"key":"10.1016\/j.jds.2023.04.026_bib19","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1007\/s00784-020-03632-7","article-title":"Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high dose bone-modifying agents?","volume":"25","author":"Ueda","year":"2021","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.jds.2023.04.026_bib20","article-title":"Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction","author":"Moreno-Rabi\u00e9","year":"2023","journal-title":"Oral Dis"},{"key":"10.1016\/j.jds.2023.04.026_bib21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jcms.2016.07.026","article-title":"Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid \u2013 a prospective study over 6 years","volume":"44","author":"M\u00fccke","year":"2016","journal-title":"J Cranio-Maxillo-Fac Surg"}],"container-title":["Journal of Dental Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790223001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1991790223001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:16:51Z","timestamp":1761851811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1991790223001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1991790223001216"],"URL":"https:\/\/doi.org\/10.1016\/j.jds.2023.04.026","relation":{},"ISSN":["1991-7902"],"issn-type":[{"value":"1991-7902","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Dental Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jds.2023.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}